Filing Details
- Accession Number:
- 0001209191-22-051592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-30 10:22:59
- Reporting Period:
- 2022-09-29
- Accepted Time:
- 2022-09-30 10:22:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780556 | David Jakeman | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-09-29 | 4,400 | $1.86 | 127,532 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit award granted on September 26, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8601 to $1.8605, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- Includes 14,266 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2022.
Billionaire Hedge Funds
